Agent Trial
Trading Prediction Markets AI Agent Context Fastest News API Agent Trial Log In Sign Up
News Wire / health

New Pancreatic Cancer Treatment Doubles Survival Time

Mastodon 17h1h Impact 5
The use of a PCSK9 inhibitor was linked with significantly better survival in patients with certain cancers treated with immune checkpoint inhibitors. This development offers new hope for treating one of the most aggressive forms of the disease.

Topics

PCSK9 inhibitor cancer treatment immune checkpoint inhibitors

Developing

  1. 883d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
  2. 883d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
  3. 883d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
  4. 883d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.

Sources · 7 independent

Mastodon

“A daily pill doubles the survival time of people with pancreatic cancer, one of the most aggressive and difficult-to-treat forms of the condition, even after they stop responding to chemother...”

PBS

“A medical breakthrough in the fight against pancreatic cancer is showing promising results after decades of research.”

Bluesky Social

“My dad was diagnosed with pancreatic cancer on July 12th, 2011 and was gone on August 4th, 2011”

Mastodon

“Incredible! Scientists receive a rare standing ovation after announcing that a new treatment can double the survival time for pancreatic cancer, the deadliest cancer which was once considered “undrugg...”

Unlock the full story

Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.

Log in to upgrade